NCT03371095 Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease Status COMPLETED Phase PHASE3
NCT03370601 Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory Diseases Status TERMINATED Phase NA
NCT03221166 Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic Factors Status TERMINATED Phase PHASE3
NCT03209232 Infliximab Accelerated Induction in Moderate to Severe Pediatric UC Status TERMINATED Phase NA
NCT03151525 Two Therapeutic Strategies for the Maintenance of Remission in Patients With Ulcerative Colitis Status UNKNOWN Phase PHASE4
NCT03112603 A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3) Status COMPLETED Phase PHASE3
NCT03100253 Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation Status TERMINATED Phase PHASE4
NCT03088293 Cyclophosphamide vs. Infliximab for Refractory Idiopathic Scleritis (CIRIS) Status WITHDRAWN Phase PHASE3
NCT03016260 RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis Status TERMINATED Phase N/A
NCT03006393 Dynamics of Inflammation and Its Blockade on Motivational Circuitry in Depression Status COMPLETED Phase PHASE4
NCT02937701 Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Infliximab Status COMPLETED Phase PHASE3
NCT02878161 Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World" Status UNKNOWN Phase PHASE4
NCT02799615 Anti-TNF Therapy for Refractory Colitis in Hospitalized Children Status COMPLETED Phase N/A
NCT02770794 Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT02770040 Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis Status COMPLETED Phase PHASE4
NCT02743390 Effects of the TNF-alpha Inhibiton on Hemodynamic Parameters in Resistant Hypertension Status COMPLETED Phase PHASE4